Adenocarcinoma of the gastroesophageal junction - Influence of esophageal resection margin and operative approach on outcome

被引:189
作者
Barbour, Andrew P.
Rizk, Nabil P.
Gonen, Mithat
Tang, Laura
Bains, Manjit S.
Rusch, Valerie W.
Coit, Daniel G.
Brennan, Murray F.
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol Biostat, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
关键词
D O I
10.1097/01.sla.0000255563.65157.d2
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: To determine whether the length of esophageal resection or the operative approach influences outcome for patients with adenocarcinoma of the gastroesophageal junction (GEJ). Summary Background Data: While R0 resection remains the mainstay of curative treatment of patients with GEJ cancer, the optimal length of esophageal resection remains controversial. Methods: Patients with Siewert I, II, or III adenocarcinoma who underwent complete gross resection without neoadjuvant therapy were identified from a prospectively maintained database. Proximal margin lengths were recorded ex vivo as the distance from the gross tumor edge to the esophageal transection line. Operative approaches were grouped into gastrectomy (limited esophagectomy) or esophagectomy (extended esophagectomy). Results: From 1985 through 2003, 505 patients underwent R0/R1 gastrectomy (n = 153) or esophagectomy (n = 352) without neoadjuvant treatment. There were no differences in R I resection rate, number of nodes examined or operative mortality between gastrectomy and esophagectomy. Univariate analysis found > 3.8 cm to be the ex vivo proximal margin length (approximately 5 ern in situ) most predictive of improved survival. Multivariable analysis in patients who underwent R0 resection with >= 15 lymph nodes examined (n = 275) found the number of positive lymph nodes, T stage, tumor grade, and ex vivo proximal margin length >3.8 cm to be independent prognostic factors. Subset analysis found that the benefit associated with > 3.8 cm margin was limited to patients with T2 or greater tumors and <= 6 positive lymph nodes. Conclusions: In patients not receiving neoadjuvant therapy, the goal for patients with adenocarcinoma of the GEJ should be R0 resection including at least 15 lymph nodes, preferably with 5 cm of grossly normal in situ proximal esophagus for those with <= 6 positive lymph nodes. The operative approach may be individualized to achieve these goals.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 45 条
[1]   En bloc esophagectomy improves survival for stage III esophageal cancer [J].
Altorki, NK ;
Girardi, L ;
Skinner, DB .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1997, 114 (06) :948-955
[2]   Surgical treatment of gastric cancer invading the oesophagus [J].
Bozzetti, F ;
Bignami, P ;
Bertario, L ;
Fissi, S ;
Eboli, M .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2000, 26 (08) :810-814
[3]   Epidemiology of upper gastrointestinal malignancies [J].
Crew, KD ;
Neugut, AI .
SEMINARS IN ONCOLOGY, 2004, 31 (04) :450-464
[4]   The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction [J].
Dresner, SM ;
Lamb, PJ ;
Bennett, MK ;
Hayes, N ;
Griffin, SM .
SURGERY, 2001, 129 (01) :103-109
[5]   Esophagogastrectomy for carcinoma of the esophagus and cardia: A comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria [J].
Ellis, FH ;
Heatley, GJ ;
Krasna, MJ ;
Williamson, WA ;
Balogh, K .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1997, 113 (05) :836-846
[6]   Positive proximal resection margins after resection for carcinoma of the oesophagus and stomach: Effect on survival and symptom recurrence [J].
Gall, CA ;
Rieger, NA ;
Wattchow, DA .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1996, 66 (11) :734-737
[7]   Curative resection for esophageal adenocarcinoma - Analysis of 100 en bloc esophagectomies [J].
Hagen, JA ;
DeMeester, SR ;
Peters, JH ;
Chandrasoma, P ;
DeMeester, TR .
ANNALS OF SURGERY, 2001, 234 (04) :520-530
[8]   Extended Lymphadenectomy Is Associated with a Survival Benefit for Node-Negative Gastric Cancer [J].
Harrison L.E. ;
Karpeh M.S. ;
Brennan M.F. .
Journal of Gastrointestinal Surgery, 1998, 2 (2) :126-131
[9]   Proximal gastric cancers resected via a transabdominal-only approach - Results and comparisons to distal adenocarcinoma of the stomach [J].
Harrison, LE ;
Karpeh, MS ;
Brennan, MF .
ANNALS OF SURGERY, 1997, 225 (06) :678-683
[10]  
HILL S, 1992, EUR J SURG ONCOL, V18, P282